Form 8-K - Current report:
SEC Accession No. 0000950103-16-018637
Filing Date
2016-12-12
Accepted
2016-12-12 17:29:38
Documents
4
Period of Report
2016-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp71056_8k.htm 8-K 13601
2 EXHIBIT 99.1 dp71056_ex9901.htm EX-99.1 12449
3 GRAPHIC image_001.jpg GRAPHIC 774861
4 GRAPHIC logo.jpg GRAPHIC 5563
  Complete submission text file 0000950103-16-018637.txt   1098259
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 162047098
SIC: 2834 Pharmaceutical Preparations